fixed interest rate from 2.05 to 3.01 percent per annum to reduce financial cost and risk management from floating interest rate. As a result, the Company has saved interest expense approximately by Baht
2,451 44 1.8 Selling and administrative expenses 305 312 (7) -2.2 Total expenses 2,800 2,763 37 1.3 Profit from operating activities 1,089 1,362 (273) -20.0 Finance cost 379 305 74 24.3 Interest expense
. In order to maintain overall financial results, the Company has initiated strategies focused on improvements in operational efficiency and expense control, such as adapting to the ‘new normal’ of
) -34.6 Cost of service 2,591 2,393 198 8.3 Selling and administrative expenses 303 276 27 9.8 Finance cost 328 312 16 5.1 Interest expense from the MRT Purple Line Project 94 108 (14) -13.0 Total expenses
for sales staff, traveling and vehicle expense for sales staff, cost of advertisement media for product promotion, compensation paid to Zuellig Pharma Ltd. under the Distribution Agreement and
expense for sales staff, cost of advertisement media for product promotion, compensation paid to Zuellig Pharma Ltd. under the Distribution Agreement and compensation for distribution of the Company’s
-39.91 -30.16 -41.62 11.46 -27.53 Income tax (expense) revenue -1.56 0.46 4.70 -2.02 -439.13 -6.26 -133.19 -1.10 8.27 -9.37 -113.30 Actuarial gain (loss) - - - - - - - - 0.41 -0.41 -100 Net profit (loss
-24.31 3.46 -24.21 13.48 -55.45 -41.00 -65.92 24.92 -37.80 Income tax (expense) revenue 0.53 -1.56 0.39 2.09 -133.97 0.14 35.90 -0.57 8.66 -9.23 -106.58 Actuarial gain (loss) - - - - - - - - 0.41 -0.41
56.90 34.89 Finance costs - Existing businesses 19.63 31.49 (11.86) Finance costs - Solar energy 26.33 1.80 24.52 Profit before income tax 45.84 23.61 22.23 Income tax expense 2.41 4.26 (1.84) Total